{"id":"faa1a6600839","type":"article","url":"https://hartvaat.nl/2025/01/01/timing-van-cardiovasculaire-en-renale-voordelen-van-finerenon-bij-hartfalen-en-c/","title":"Timing van cardiovasculaire en renale voordelen van finerenon bij hartfalen en CKD met diabetes","title_en":"Timing of Cardiovascular and Kidney Benefits With Finerenone in Heart Failure and Chronic Kidney Disease With Type 2 Diabetes","category":"hartfalen","category_label":"Hartfalen","professions":["apotheker","cardioloog","internist"],"tags":["acuut-hartfalen","anemie-ckd","biomarkers-cardiovasculair","cardio-renaal-metabool","cardiorenal-behandelstrategie","chronische-nierziekte","credence-trial","diabetes-en-hart","diabetes-type-1","diabetes-type-2","fidelio-dkd","fidelity","figaro-dkd","finerenon-hartfalen-nierziekte","flow-trial","ijzertekort","myocardinfarct","ouderen"],"journal":"JACC","doi":"https://www.sciencedirect.com/science/article/pii/S0735109725100715?dgcid=rss_sd_all","source_url":"https://doi.org/https://www.sciencedirect.com/science/article/pii/S0735109725100715?dgcid=rss_sd_all","authors":["John W. Ostrominski","Brendon L. Neuen","Brian L. Claggett","Gerasimos Filippatos","Akshay S. Desai","Pardeep S. Jhund","Alasdair Henderson","Carolyn S.P. Lam","Michele Senni","Sanjiv J. Shah"],"significance":8,"published":"2026-03-01","source_date":"2025-01-01","image":"","kennis":["https://hartvaat.nl/kennis/farmacologie/sglt2-remmers-cardiovasculaire-trials/"],"congress":"","summary_en":"This JACC analysis examined the time course of cardiovascular and kidney benefits with finerenone in patients with heart failure and chronic kidney disease with type 2 diabetes, characterizing how quickly the cardiorenal protection emerges after treatment initiation.","created":"2026-07-03T10:25:45Z","updated":"2026-07-03T18:38:18Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Analyse in JACC over het tijdsverloop van de cardiovasculaire en niergerelateerde voordelen van finerenon bij patiënten met hartfalen en chronische nierziekte bij diabetes type 2.","abstract_original":"Publication date: 24 February 2026Source: JACC, Volume 87, Issue 7"}